How UltraSight used data-driven strategy to identify the right markets and accelerate investor confidence

UltraSight, an AI-driven cardiac imaging software company, needed to quantify its market opportunity and validate business model scalability with credible third-party data to strengthen its investor narrative, operating in hospital systems that are "fragmented, shift-driven, and challenged by high staff turnover." It built a market validation framework with Definitive Healthcare data, quantifying patient volumes across ten CCS codes and mapping care pathways for who received echocardiograms inpatient, within two weeks, or not at all; combining this with field feedback led to a strategic shift toward outpatient echo labs. The work produced a clear investor narrative, identified an opportunity to redirect sonographer capacity toward billable outpatient work to relieve operational pressure and create new revenue streams, and enabled a 20-person field team to tailor account-specific conversations; CCO Ramya Singh said, "Definitive's data helped us validate [our hypothesis] with confidence."

Definitive Healthcare is a claims and provider-reference data platform used by pharma commercial teams for go-to-market planning and sales targeting.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.